Harvard Bioscience (HBIO) Shares Outstanding (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Shares Outstanding (Entity) of $4.5 million for Q1 2026, up 2.03% year-over-year from $4.4 million in Q1 2025, and up 0.87% quarter-over-quarter from $4.5 million in Q4 2025.
Harvard Bioscience (HBIO) Shares Outstanding (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Shares Outstanding (Entity) for 17 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 2.03% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 2.03% YoY), while the FY2025 annual figure was $4.5 million, up 1.47% from the prior year.
- Shares Outstanding (Entity) improved to $4.5 million in Q1 2026 per HBIO's latest filing, from $4.5 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $4.5 million in Q1 2026 and bottomed at $4.1 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $4.3 million across 5 years, with a median of $4.3 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) dropped 13.53% — and 2023, when it rose 3.12%.
- Harvard Bioscience's Shares Outstanding (Entity) stood at $4.2 million in 2022, then grew by 3.12% to $4.3 million in 2023, then rose by 1.56% to $4.4 million in 2024, then grew by 1.47% to $4.5 million in 2025, then gained by 0.87% to $4.5 million in 2026.
- Business Quant data shows HBIO's Shares Outstanding (Entity) at $4.5 million in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.53 Mn |
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 4.44 Mn |
| Sep 30, 2025 | 4.46 Mn |
| Jun 30, 2025 | 4.43 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Sep 30, 2024 | 4.36 Mn |
| Jun 30, 2024 | 4.35 Mn |
| Mar 31, 2024 | 4.34 Mn |
| Dec 31, 2023 | 4.24 Mn |
| Sep 30, 2023 | 4.27 Mn |
| Jun 30, 2023 | 4.24 Mn |
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 4.14 Mn |
| Sep 30, 2022 | 4.16 Mn |
| Jun 30, 2022 | 4.13 Mn |
| Mar 31, 2022 | 4.12 Mn |
| Dec 31, 2021 | 4.03 Mn |
| Sep 30, 2021 | 4.08 Mn |